UniProt ID | WDR44_HUMAN | |
---|---|---|
UniProt AC | Q5JSH3 | |
Protein Name | WD repeat-containing protein 44 | |
Gene Name | WDR44 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 913 | |
Subcellular Localization | Cytoplasm, cytosol. Cytoplasm, perinuclear region. Endosome membrane. Golgi apparatus, trans-Golgi network. Colocalized with RAB11 along microtubules oriented toward lamellipodia.. | |
Protein Description | Downstream effector for RAB11. May be involved in vesicle recycling (By similarity).. | |
Protein Sequence | MASESDTEEFYDAPEDVHLGGGYPVGSPGKVGLSTFKETENTAYKVGNESPVQELKQDVSKKIIESIIEESQKVLQLEDDSLDSKGKELSDQATASPIVARTDLSNIPGLLAIDQVLPEESQKAESQNTFEETELELKKCFPSDETCEKPVDETTKLTQTSSTEQLNVLETETEVLNKEAVEVKGGGDVLEPVSSDSLSTKDFAAVEEVAPAKPPRHLTPEPDIVASTKKPVPARPPPPTNFPPPRPPPPSRPAPPPRKRKSELEFETLKTPDIDVPKENITSDSLLTASMASESTVKDSQPSLDLASATSGDKIVTAQENGKAPDGQTVAGEVMGPQRPRSNSGRELTDEEILASVMIKNLDTGEEIPLSLAEEKLPTGINPLTLHIMRRTKEYVSNDAAQSDDEEKLQSQPTDTDGGRLKQKTTQLKKFLGKSVKRAKHLAEEYGERAINKVKSVRDEVFHTDQDDPSSSDDEGMPYTRPVKFKAAHGFKGPYDFDQIKVVQDLSGEHMGAVWTMKFSHCGRLLASAGQDNVVRIWALKNAFDYFNNMRMKYNTEGRVSPSPSQESLSSSKSDTDTGVCSGTDEDPDDKNAPFRQRPFCKYKGHTADLLDLSWSKNYFLLSSSMDKTVRLWHISRRECLCCFQHIDFVTAIAFHPRDDRYFLSGSLDGKLRLWNIPDKKVALWNEVDGQTKLITAANFCQNGKYAVIGTYDGRCIFYDTEHLKYHTQIHVRSTRGRNKVGRKITGIEPLPGENKILVTSNDSRIRLYDLRDLSLSMKYKGYVNSSSQIKASFSHDFTYLVSGSEDKYVYIWSTYHDLSKFTSVRRDRNDFWEGIKAHNAVVTSAIFAPNPSLMLSLDVQSEKSEGNEKSEDAEVLDATPSGIMKTDNTEVLLSADFTGAIKVFVNKRKNVS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASESDTEE ------CCCCCCHHC | 23.23 | 20068231 | |
3 | Phosphorylation | -----MASESDTEEF -----CCCCCCHHCH | 36.01 | 25159151 | |
5 | Phosphorylation | ---MASESDTEEFYD ---CCCCCCHHCHHC | 47.54 | 25159151 | |
7 | Phosphorylation | -MASESDTEEFYDAP -CCCCCCHHCHHCCC | 46.85 | 25159151 | |
11 | Phosphorylation | ESDTEEFYDAPEDVH CCCHHCHHCCCCCCC | 17.93 | 22115753 | |
23 | Phosphorylation | DVHLGGGYPVGSPGK CCCCCCCCCCCCCCC | 9.68 | 22115753 | |
27 | Phosphorylation | GGGYPVGSPGKVGLS CCCCCCCCCCCCCCC | 30.61 | 25159151 | |
34 | Phosphorylation | SPGKVGLSTFKETEN CCCCCCCCCCCCCCC | 26.35 | 26074081 | |
35 | Phosphorylation | PGKVGLSTFKETENT CCCCCCCCCCCCCCC | 43.71 | 26074081 | |
39 | Phosphorylation | GLSTFKETENTAYKV CCCCCCCCCCCCEEC | 34.82 | 23403867 | |
42 | Phosphorylation | TFKETENTAYKVGNE CCCCCCCCCEECCCC | 25.73 | 23403867 | |
44 | Phosphorylation | KETENTAYKVGNESP CCCCCCCEECCCCCH | 12.27 | 23403867 | |
45 (in isoform 3) | Ubiquitination | - | 41.00 | 21890473 | |
50 | Phosphorylation | AYKVGNESPVQELKQ CEECCCCCHHHHHHH | 34.08 | 19664994 | |
60 | Phosphorylation | QELKQDVSKKIIESI HHHHHHHHHHHHHHH | 36.20 | 23403867 | |
66 | Phosphorylation | VSKKIIESIIEESQK HHHHHHHHHHHHHHH | 20.61 | 23186163 | |
71 | Phosphorylation | IESIIEESQKVLQLE HHHHHHHHHHHHCCC | 23.63 | 29970186 | |
81 | Phosphorylation | VLQLEDDSLDSKGKE HHCCCCCCCCCCCHH | 46.53 | 23401153 | |
84 | Phosphorylation | LEDDSLDSKGKELSD CCCCCCCCCCHHHCH | 48.91 | 30266825 | |
85 | 2-Hydroxyisobutyrylation | EDDSLDSKGKELSDQ CCCCCCCCCHHHCHH | 73.92 | - | |
87 | Acetylation | DSLDSKGKELSDQAT CCCCCCCHHHCHHHC | 60.25 | 23954790 | |
90 | Phosphorylation | DSKGKELSDQATASP CCCCHHHCHHHCCCC | 28.86 | 25159151 | |
94 | Phosphorylation | KELSDQATASPIVAR HHHCHHHCCCCCEEC | 23.26 | 25159151 | |
96 | Phosphorylation | LSDQATASPIVARTD HCHHHCCCCCEECCC | 15.71 | 19664994 | |
102 | Phosphorylation | ASPIVARTDLSNIPG CCCCEECCCHHCCCH | 31.39 | 29514088 | |
105 | Phosphorylation | IVARTDLSNIPGLLA CEECCCHHCCCHHHH | 35.21 | 29514088 | |
126 | Phosphorylation | EESQKAESQNTFEET HHHHHHHHCCCHHHH | 33.32 | 23663014 | |
129 | Phosphorylation | QKAESQNTFEETELE HHHHHCCCHHHHHHH | 25.45 | 23663014 | |
143 | Phosphorylation | ELKKCFPSDETCEKP HHHHHCCCCCCCCCC | 28.03 | 28060719 | |
146 | Phosphorylation | KCFPSDETCEKPVDE HHCCCCCCCCCCCCC | 30.84 | 30624053 | |
154 | Phosphorylation | CEKPVDETTKLTQTS CCCCCCCCCEEEECC | 25.43 | 30624053 | |
155 | Phosphorylation | EKPVDETTKLTQTSS CCCCCCCCEEEECCC | 23.24 | 30624053 | |
158 | Phosphorylation | VDETTKLTQTSSTEQ CCCCCEEEECCCHHH | 31.21 | 22167270 | |
160 | Phosphorylation | ETTKLTQTSSTEQLN CCCEEEECCCHHHHC | 21.29 | 22167270 | |
161 | Phosphorylation | TTKLTQTSSTEQLNV CCEEEECCCHHHHCE | 25.99 | 22167270 | |
162 | Phosphorylation | TKLTQTSSTEQLNVL CEEEECCCHHHHCEE | 39.07 | 22167270 | |
163 | Phosphorylation | KLTQTSSTEQLNVLE EEEECCCHHHHCEEE | 27.76 | 22167270 | |
171 | Phosphorylation | EQLNVLETETEVLNK HHHCEEEEEEEECCC | 44.01 | 23927012 | |
173 | Phosphorylation | LNVLETETEVLNKEA HCEEEEEEEECCCHH | 38.52 | 23403867 | |
194 | Phosphorylation | GDVLEPVSSDSLSTK CCCCCCCCCCCCCCC | 38.86 | 25159151 | |
195 | Phosphorylation | DVLEPVSSDSLSTKD CCCCCCCCCCCCCCC | 31.30 | 25159151 | |
197 | Phosphorylation | LEPVSSDSLSTKDFA CCCCCCCCCCCCCCH | 26.60 | 23401153 | |
199 | Phosphorylation | PVSSDSLSTKDFAAV CCCCCCCCCCCCHHH | 37.05 | 25159151 | |
200 | Phosphorylation | VSSDSLSTKDFAAVE CCCCCCCCCCCHHHH | 39.67 | 30266825 | |
201 | Ubiquitination | SSDSLSTKDFAAVEE CCCCCCCCCCHHHHH | 47.69 | - | |
213 | Ubiquitination | VEEVAPAKPPRHLTP HHHHCCCCCCCCCCC | 55.27 | - | |
213 | Acetylation | VEEVAPAKPPRHLTP HHHHCCCCCCCCCCC | 55.27 | 25953088 | |
219 | Phosphorylation | AKPPRHLTPEPDIVA CCCCCCCCCCCCCCC | 21.34 | 23401153 | |
227 | Phosphorylation | PEPDIVASTKKPVPA CCCCCCCCCCCCCCC | 29.84 | 23403867 | |
228 | Phosphorylation | EPDIVASTKKPVPAR CCCCCCCCCCCCCCC | 33.09 | 23403867 | |
251 | Phosphorylation | PPRPPPPSRPAPPPR CCCCCCCCCCCCCCC | 57.58 | 22210691 | |
261 | Ubiquitination | APPPRKRKSELEFET CCCCCCCCCHHCEEE | 51.85 | - | |
262 | Phosphorylation | PPPRKRKSELEFETL CCCCCCCCHHCEEEC | 51.99 | 19664994 | |
268 | Phosphorylation | KSELEFETLKTPDID CCHHCEEECCCCCCC | 38.58 | 22617229 | |
271 | Phosphorylation | LEFETLKTPDIDVPK HCEEECCCCCCCCCH | 29.34 | 29255136 | |
282 | Phosphorylation | DVPKENITSDSLLTA CCCHHHCCCHHHHHH | 37.75 | 26503514 | |
283 (in isoform 3) | Ubiquitination | - | 22.77 | 21890473 | |
285 | Phosphorylation | KENITSDSLLTASMA HHHCCCHHHHHHHHC | 25.66 | 28555341 | |
288 | Phosphorylation | ITSDSLLTASMASES CCCHHHHHHHHCCCC | 23.21 | 26503514 | |
290 | Phosphorylation | SDSLLTASMASESTV CHHHHHHHHCCCCCC | 15.05 | 26503514 | |
300 | Phosphorylation | SESTVKDSQPSLDLA CCCCCCCCCCCCCCC | 37.97 | 20068231 | |
303 | Phosphorylation | TVKDSQPSLDLASAT CCCCCCCCCCCCCCC | 27.21 | 20068231 | |
308 | Phosphorylation | QPSLDLASATSGDKI CCCCCCCCCCCCCEE | 39.10 | 20068231 | |
310 | Phosphorylation | SLDLASATSGDKIVT CCCCCCCCCCCEEEE | 30.65 | 20068231 | |
311 | Phosphorylation | LDLASATSGDKIVTA CCCCCCCCCCEEEEE | 44.72 | 20068231 | |
329 | Phosphorylation | GKAPDGQTVAGEVMG CCCCCCCCCCCEECC | 20.18 | 26074081 | |
342 | Phosphorylation | MGPQRPRSNSGRELT CCCCCCCCCCCCCCC | 37.72 | 26846344 | |
344 | Phosphorylation | PQRPRSNSGRELTDE CCCCCCCCCCCCCHH | 40.24 | 26846344 | |
349 | Phosphorylation | SNSGRELTDEEILAS CCCCCCCCHHHHHHH | 36.29 | 26846344 | |
356 | Phosphorylation | TDEEILASVMIKNLD CHHHHHHHHHEECCC | 14.58 | 23403867 | |
392 | Phosphorylation | TLHIMRRTKEYVSND HHHHHHHCHHHHCCC | 20.19 | 30266825 | |
395 | Phosphorylation | IMRRTKEYVSNDAAQ HHHHCHHHHCCCHHC | 15.67 | 30266825 | |
397 | Phosphorylation | RRTKEYVSNDAAQSD HHCHHHHCCCHHCCC | 28.26 | 23401153 | |
403 | Phosphorylation | VSNDAAQSDDEEKLQ HCCCHHCCCCHHHHH | 42.16 | 19664994 | |
411 | Phosphorylation | DDEEKLQSQPTDTDG CCHHHHHHCCCCCCC | 48.87 | 30266825 | |
414 | Phosphorylation | EKLQSQPTDTDGGRL HHHHHCCCCCCCCHH | 43.84 | 30266825 | |
416 | Phosphorylation | LQSQPTDTDGGRLKQ HHHCCCCCCCCHHCH | 38.74 | 30266825 | |
422 | Ubiquitination | DTDGGRLKQKTTQLK CCCCCHHCHHHHHHH | 48.68 | - | |
426 | Phosphorylation | GRLKQKTTQLKKFLG CHHCHHHHHHHHHHC | 38.65 | 18077418 | |
434 | Acetylation | QLKKFLGKSVKRAKH HHHHHHCHHHHHHHH | 54.98 | 7213989 | |
434 | Ubiquitination | QLKKFLGKSVKRAKH HHHHHHCHHHHHHHH | 54.98 | - | |
435 | Phosphorylation | LKKFLGKSVKRAKHL HHHHHCHHHHHHHHH | 30.95 | 23401153 | |
437 | Acetylation | KFLGKSVKRAKHLAE HHHCHHHHHHHHHHH | 54.45 | 7213999 | |
440 | Ubiquitination | GKSVKRAKHLAEEYG CHHHHHHHHHHHHHH | 43.09 | 21906983 | |
440 (in isoform 1) | Ubiquitination | - | 43.09 | 21890473 | |
440 (in isoform 2) | Ubiquitination | - | 43.09 | 21890473 | |
446 | Phosphorylation | AKHLAEEYGERAINK HHHHHHHHHHHHHHH | 18.78 | 28674419 | |
456 | Phosphorylation | RAINKVKSVRDEVFH HHHHHHHHHHHHCCC | 25.93 | 20068231 | |
464 | Phosphorylation | VRDEVFHTDQDDPSS HHHHCCCCCCCCCCC | 24.72 | 21955146 | |
470 | Phosphorylation | HTDQDDPSSSDDEGM CCCCCCCCCCCCCCC | 49.85 | 21955146 | |
471 | Phosphorylation | TDQDDPSSSDDEGMP CCCCCCCCCCCCCCC | 43.08 | 25159151 | |
472 | Phosphorylation | DQDDPSSSDDEGMPY CCCCCCCCCCCCCCC | 54.11 | 25159151 | |
479 | Phosphorylation | SDDEGMPYTRPVKFK CCCCCCCCCCCCEEE | 13.39 | 25072903 | |
480 | Phosphorylation | DDEGMPYTRPVKFKA CCCCCCCCCCCEEEE | 23.72 | 21601212 | |
486 | Ubiquitination | YTRPVKFKAAHGFKG CCCCCEEEECCCCCC | 38.66 | - | |
492 | Ubiquitination | FKAAHGFKGPYDFDQ EEECCCCCCCCCHHH | 64.66 | - | |
493 | Ubiquitination | KAAHGFKGPYDFDQI EECCCCCCCCCHHHE | 24.60 | 21890473 | |
495 | Phosphorylation | AHGFKGPYDFDQIKV CCCCCCCCCHHHEEE | 37.60 | - | |
507 | Phosphorylation | IKVVQDLSGEHMGAV EEEEEECCCCCCCEE | 50.88 | 26503892 | |
516 | Phosphorylation | EHMGAVWTMKFSHCG CCCCEEEEEEECHHH | 12.13 | 26503892 | |
518 | Ubiquitination | MGAVWTMKFSHCGRL CCEEEEEEECHHHHH | 36.02 | 21890473 | |
518 (in isoform 1) | Ubiquitination | - | 36.02 | 21890473 | |
518 (in isoform 2) | Ubiquitination | - | 36.02 | 21890473 | |
528 | Phosphorylation | HCGRLLASAGQDNVV HHHHHHHHCCCCHHH | 32.66 | - | |
546 | Phosphorylation | ALKNAFDYFNNMRMK EHHHHHHHHHCCCCE | 11.18 | 26503514 | |
554 | Phosphorylation | FNNMRMKYNTEGRVS HHCCCCEECCCCCCC | 20.27 | 23927012 | |
556 | Phosphorylation | NMRMKYNTEGRVSPS CCCCEECCCCCCCCC | 36.41 | 23927012 | |
561 | Phosphorylation | YNTEGRVSPSPSQES ECCCCCCCCCCCHHH | 20.49 | 19664994 | |
563 | Phosphorylation | TEGRVSPSPSQESLS CCCCCCCCCCHHHHH | 29.67 | 23927012 | |
565 | Phosphorylation | GRVSPSPSQESLSSS CCCCCCCCHHHHHCC | 51.41 | 29255136 | |
568 | Phosphorylation | SPSPSQESLSSSKSD CCCCCHHHHHCCCCC | 26.39 | 17525332 | |
570 | Phosphorylation | SPSQESLSSSKSDTD CCCHHHHHCCCCCCC | 41.67 | 29255136 | |
571 | Phosphorylation | PSQESLSSSKSDTDT CCHHHHHCCCCCCCC | 47.26 | 29255136 | |
572 | Phosphorylation | SQESLSSSKSDTDTG CHHHHHCCCCCCCCC | 32.57 | 29255136 | |
574 | Phosphorylation | ESLSSSKSDTDTGVC HHHHCCCCCCCCCCC | 47.92 | 23927012 | |
576 | Phosphorylation | LSSSKSDTDTGVCSG HHCCCCCCCCCCCCC | 42.42 | 30278072 | |
578 | Phosphorylation | SSKSDTDTGVCSGTD CCCCCCCCCCCCCCC | 33.34 | 23927012 | |
582 | Phosphorylation | DTDTGVCSGTDEDPD CCCCCCCCCCCCCCC | 42.17 | 23401153 | |
584 | Phosphorylation | DTGVCSGTDEDPDDK CCCCCCCCCCCCCCC | 21.66 | 23927012 | |
614 | Phosphorylation | TADLLDLSWSKNYFL CCEECCCCCCCCEEE | 29.04 | 19664995 | |
619 | Phosphorylation | DLSWSKNYFLLSSSM CCCCCCCEEEECCCC | 10.19 | 29759185 | |
662 | Phosphorylation | FHPRDDRYFLSGSLD CCCCCCCEEEEEECC | 18.83 | 23186163 | |
665 | Phosphorylation | RDDRYFLSGSLDGKL CCCCEEEEEECCCEE | 19.21 | 23186163 | |
667 | Phosphorylation | DRYFLSGSLDGKLRL CCEEEEEECCCEEEE | 21.66 | 23186163 | |
667 | Ubiquitination | DRYFLSGSLDGKLRL CCEEEEEECCCEEEE | 21.66 | 21890473 | |
671 | Ubiquitination | LSGSLDGKLRLWNIP EEEECCCEEEEEECC | 30.05 | - | |
681 | Ubiquitination | LWNIPDKKVALWNEV EEECCCCEEEEEEEC | 39.87 | - | |
696 | Phosphorylation | DGQTKLITAANFCQN CCCEEEEEEEHHHHC | 30.10 | 21406692 | |
744 | Ubiquitination | GRNKVGRKITGIEPL CCCCCCCEECCCCCC | 38.40 | - | |
756 | Ubiquitination | EPLPGENKILVTSND CCCCCCCCEEEECCC | 32.87 | 21890473 | |
756 (in isoform 1) | Ubiquitination | - | 32.87 | 21890473 | |
756 (in isoform 2) | Ubiquitination | - | 32.87 | 21890473 | |
777 | Phosphorylation | DLRDLSLSMKYKGYV EHHHCCEEEEECEEC | 15.17 | 24719451 | |
779 | Acetylation | RDLSLSMKYKGYVNS HHCCEEEEECEECCC | 40.20 | 19813317 | |
781 | Acetylation | LSLSMKYKGYVNSSS CCEEEEECEECCCCH | 37.94 | 19813325 | |
781 | Ubiquitination | LSLSMKYKGYVNSSS CCEEEEECEECCCCH | 37.94 | - | |
783 | Phosphorylation | LSMKYKGYVNSSSQI EEEEECEECCCCHHE | 7.72 | 22817900 | |
799 | Phosphorylation | ASFSHDFTYLVSGSE EEECCCEEEEEECCC | 23.23 | 22817900 | |
800 | Phosphorylation | SFSHDFTYLVSGSED EECCCEEEEEECCCC | 12.71 | 22817900 | |
803 | Phosphorylation | HDFTYLVSGSEDKYV CCEEEEEECCCCCEE | 33.72 | - | |
809 | Phosphorylation | VSGSEDKYVYIWSTY EECCCCCEEEEEEEE | 15.71 | 27251275 | |
823 | Phosphorylation | YHDLSKFTSVRRDRN ECCHHHHHHCCCCCC | 30.01 | 25332170 | |
870 | Ubiquitination | EKSEGNEKSEDAEVL CCCCCCCCCCCCCHH | 64.24 | - | |
871 | Phosphorylation | KSEGNEKSEDAEVLD CCCCCCCCCCCCHHH | 34.23 | 25159151 | |
880 | Phosphorylation | DAEVLDATPSGIMKT CCCHHHCCCCCEECC | 20.04 | 21815630 | |
882 | Phosphorylation | EVLDATPSGIMKTDN CHHHCCCCCEECCCC | 36.27 | 21815630 | |
885 | Sulfoxidation | DATPSGIMKTDNTEV HCCCCCEECCCCCEE | 4.33 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WDR44_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WDR44_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WDR44_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VATH_HUMAN | ATP6V1H | physical | 22863883 | |
OSB11_HUMAN | OSBPL11 | physical | 22863883 | |
PRP39_HUMAN | PRPF39 | physical | 22863883 | |
VAPB_HUMAN | VAPB | physical | 24885147 | |
ACSF2_HUMAN | ACSF2 | physical | 28514442 | |
ASML_HUMAN | ASMTL | physical | 28514442 | |
PDP1_HUMAN | PDP1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5; SER-50; SER-90; SER-96; THR-158; SER-161;SER-162; THR-163; SER-403; SER-561; SER-563 AND SER-565, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-96 AND SER-403,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5; SER-50; SER-90; SER-96; THR-158; SER-161;SER-162; THR-163; SER-403; SER-561; SER-563 AND SER-565, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-96; THR-219;SER-262; SER-403; SER-470; SER-471 AND SER-472, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470; SER-471; SER-472AND SER-561, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561; SER-565 ANDSER-568, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-262; THR-271;TYR-783; THR-799 AND TYR-800, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-96, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-27; SER-262 ANDSER-403, AND MASS SPECTROMETRY. |